Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8)

Andrew H. Wei; Panayiotis Panayiotidis; Pau Montesinos; Kamel Laribi; Vladimir Ivanov; Inho Kim; Jan Novak; Don A. Stevens; Walter Fiedler; Maria Pagoni; Julie Bergeron; Stephen B. Ting; Jing Zhou Hou; Achilles Anagnostopoulos; Andrew McDonald; Vidhya Murthy; Takahiro Yamauchi; Jianxiang Wang; Brenda Chyla; Yan Sun; Qi Jiang; Wellington Mendes; John Hayslip; Courtney D. DiNardo

doi:10.1038/s41408-021-00565-6

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8)

Andrew H. Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Inho Kim, Jan Novak, Don A. Stevens, Walter Fiedler, Maria Pagoni, Julie Bergeron, Stephen B. Ting, Jing Zhou Hou, Achilles Anagnostopoulos, Andrew McDonald, Vidhya Murthy, Takahiro Yamauchi, Jianxiang Wang, Brenda Chyla, Yan SunQi Jiang, Wellington Mendes, John Hayslip, Courtney D. DiNardo

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The title this article was published with was not correct. It should read “6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy”.

Original language	English (US)
Article number	171
Journal	Blood cancer journal
Volume	11
Issue number	10
DOIs	https://doi.org/10.1038/s41408-021-00565-6
State	Published - Oct 2021

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-021-00565-6

Fingerprint

Dive into the research topics of 'Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8)'. Together they form a unique fingerprint.

Cite this

Wei, A. H., Panayiotidis, P., Montesinos, P., Laribi, K., Ivanov, V., Kim, I., Novak, J., Stevens, D. A., Fiedler, W., Pagoni, M., Bergeron, J., Ting, S. B., Hou, J. Z., Anagnostopoulos, A., McDonald, A., Murthy, V., Yamauchi, T., Wang, J., Chyla, B., ... DiNardo, C. D. (2021). Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8). Blood cancer journal, 11(10), Article 171. https://doi.org/10.1038/s41408-021-00565-6

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8). / Wei, Andrew H.; Panayiotidis, Panayiotis; Montesinos, Pau et al.
In: Blood cancer journal, Vol. 11, No. 10, 171, 10.2021.

Research output: Contribution to journal › Comment/debate › peer-review

Wei, AH, Panayiotidis, P, Montesinos, P, Laribi, K, Ivanov, V, Kim, I, Novak, J, Stevens, DA, Fiedler, W, Pagoni, M, Bergeron, J, Ting, SB, Hou, JZ, Anagnostopoulos, A, McDonald, A, Murthy, V, Yamauchi, T, Wang, J, Chyla, B, Sun, Y, Jiang, Q, Mendes, W, Hayslip, J & DiNardo, CD 2021, 'Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8)', Blood cancer journal, vol. 11, no. 10, 171. https://doi.org/10.1038/s41408-021-00565-6

Wei AH, Panayiotidis P, Montesinos P, Laribi K, Ivanov V, Kim I et al. Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8). Blood cancer journal. 2021 Oct;11(10):171. doi: 10.1038/s41408-021-00565-6

@article{d475b7e4a516419d8a0ba08c1f72d6c1,

title = "Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8)",

abstract = "The title this article was published with was not correct. It should read “6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy”.",

author = "Wei, {Andrew H.} and Panayiotis Panayiotidis and Pau Montesinos and Kamel Laribi and Vladimir Ivanov and Inho Kim and Jan Novak and Stevens, {Don A.} and Walter Fiedler and Maria Pagoni and Julie Bergeron and Ting, {Stephen B.} and Hou, {Jing Zhou} and Achilles Anagnostopoulos and Andrew McDonald and Vidhya Murthy and Takahiro Yamauchi and Jianxiang Wang and Brenda Chyla and Yan Sun and Qi Jiang and Wellington Mendes and John Hayslip and DiNardo, {Courtney D.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021",

year = "2021",

month = oct,

doi = "10.1038/s41408-021-00565-6",

language = "English (US)",

volume = "11",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Author Correction

T2 - 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8)

AU - Wei, Andrew H.

AU - Panayiotidis, Panayiotis

AU - Montesinos, Pau

AU - Laribi, Kamel

AU - Ivanov, Vladimir

AU - Kim, Inho

AU - Novak, Jan

AU - Stevens, Don A.

AU - Fiedler, Walter

AU - Pagoni, Maria

AU - Bergeron, Julie

AU - Ting, Stephen B.

AU - Hou, Jing Zhou

AU - Anagnostopoulos, Achilles

AU - McDonald, Andrew

AU - Murthy, Vidhya

AU - Yamauchi, Takahiro

AU - Wang, Jianxiang

AU - Chyla, Brenda

AU - Sun, Yan

AU - Jiang, Qi

AU - Mendes, Wellington

AU - Hayslip, John

AU - DiNardo, Courtney D.

PY - 2021/10

Y1 - 2021/10

N2 - The title this article was published with was not correct. It should read “6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy”.

AB - The title this article was published with was not correct. It should read “6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy”.

UR - http://www.scopus.com/inward/record.url?scp=85118352430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118352430&partnerID=8YFLogxK

U2 - 10.1038/s41408-021-00565-6

DO - 10.1038/s41408-021-00565-6

M3 - Comment/debate

C2 - 34702803

AN - SCOPUS:85118352430

SN - 2044-5385

VL - 11

JO - Blood cancer journal

JF - Blood cancer journal

IS - 10

M1 - 171

ER -

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (Blood Cancer Journal, (2021), 11, 10, (163), 10.1038/s41408-021-00555-8)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this